Income StatementBalance SheetCash FlowSegments
Amgen logo

Amgen Income Statement

Revenue, expenses, and profitability over time

Amgen generated $37.2B in trailing twelve-month revenue, up 0.1% year-over-year. Net income was $7.8B with a 20.96% net margin. Gross margin stands at 68.26% and operating margin at 28.39%. Diluted EPS is $14.38, which grew 0.3% year-over-year. Based on the Q1 2026 filing.

Total Revenue (TTM)$37.2BGross Profit (TTM)$25.4BOperating Income (TTM)$10.6BNet Income (TTM)$7.8BEps Diluted (TTM)$14.38
Latest FilingQ1 2026
Report Date2026-04-30
Market Cap$175.17B
P/E Ratio22.46
ROE101.32%

Operating Expenses

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Stock-Based Compensation Expense$134.0M$85.0M$157.0M$127.0M$125.0M$75.0M
Impairment of Intangible Assets$30.0M$800.0M—$400.0M—$0.0
Share-Based Compensation Expense$134.0M$85.0M$157.0M$127.0M$125.0M$75.0M
Depreciation and amortization$1.4B$1.4B$1.3B$1.3B$1.1B$1.1B
Other nonrecurring (income) expense—$830.0M———-$113.0M
Stock-based compensation expense$134.0M$85.0M$157.0M$127.0M$125.0M$75.0M
Impairment of Intangible Assets (Excl. Goodwill)$30.0M$800.0M—$400.0M—$0.0
Research and development$1.7B$1.5B$1.7B$1.9B$2.1B$1.7B
Selling, general and administrative$1.9B$1.7B$1.7B$1.7B$2.0B$1.6B
Share-Based Compensation$134.0M$85.0M$157.0M$127.0M$125.0M$75.0M
Total operating expenses$6.8B$7.0B$6.5B$7.0B$7.1B$6.0B

Other Income & Expense

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Other Non-Cash Income (Expense)$38.0M$50.0M$23.0M$28.0M-$250.0M$67.0M
Unrealized Gain (Loss) on Investments-$876.0M$1.3B—$2.0B—-$143.0M
Unrealized Gain (Loss) on Equity Investments-$876.0M$1.3B—$2.0B—-$143.0M
Unrealized Gain (Loss) on Investments-$876.0M$1.3B—$2.0B—-$143.0M
Other non-cash income (expense)$38.0M$50.0M$23.0M$28.0M-$250.0M$67.0M
Change in Accounts Payable—$497.0M$589.0M——$571.0M
Other Non-Cash Income (Expense)$38.0M$50.0M$23.0M$28.0M-$250.0M$67.0M
Other income (expense), net—$1.5B-$394.0M$2.1B—$75.0M
Other Non-cash Income (Expense)$38.0M$50.0M$23.0M$28.0M-$250.0M$67.0M
Payments of Debt Extinguishment Costs—$301.0M$301.0M$81.0M$0.0$233.0M
Other Non-Cash Income (Expense)$38.0M$50.0M$23.0M$28.0M-$250.0M$67.0M
Interest expense on debt$747.0M$723.0M$694.0M$685.0M$653.0M$657.0M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Capital Expenditures$371.0M$411.0M$369.0M$436.0M$642.0M$712.0M
Change in Accounts Receivable-$473.0M$1.3B$515.0M$0.0$1.1B-$413.0M
Change in Other Liabilities—-$78.0M$0.0-$10.0M-$76.0M-$75.0M
Deferred and other income taxes-$334.0M-$250.0M-$422.0M-$30.0M-$19.0M-$176.0M
Accounts payable—$497.0M$589.0M——$571.0M
Increase (Decrease) in Accounts Receivable-$473.0M$1.3B$515.0M$0.0$1.1B-$413.0M
Increase Decrease In Accrued Income Taxes Payable—$104.0M-$2.4B—-$365.0M$71.0M
Accrued liabilities$728.0M-$874.0M$824.0M-$200.0M$749.0M-$959.0M
Increase (Decrease) in Inventories-$323.0M-$288.0M-$239.0M-$240.0M-$119.0M-$18.0M
Long-term tax liabilities—$70.0M$92.0M$74.0M$75.0M$71.0M
Increase (Decrease) in Other Operating Assets$14.0M$201.0M$206.0M$283.0M$577.0M-$8.0M
Other liabilities—-$78.0M$0.0-$10.0M-$76.0M-$75.0M
Accrued sales incentives and allowance$658.0M$486.0M$627.0M$1.2B—-$839.0M
Debt$747.0M$723.0M$694.0M$685.0M$653.0M$657.0M
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation-$1.4B-$4.1B-$2.7B-$2.9B-$1.2B$1.4B
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation-$402.0M-$447.0M-$389.0M-$414.0M-$693.0M-$716.0M
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation$4.8B$1.4B$2.3B$4.7B$1.6B$2.2B
Other Noncash Income (Expense)$38.0M$50.0M$23.0M$28.0M-$250.0M$67.0M
Payment for (Proceeds from) Other Investing Activity—$36.0M$20.0M——$4.0M
Payments of Ordinary Dividends, Common Stock$1.2B$1.3B$1.3B$1.3B$1.3B$1.4B
Payments to Acquire Property, Plant, and Equipment$371.0M$411.0M$369.0M$436.0M$642.0M$712.0M
Debt issued (Note 13)$0.0$0.0———$4.0B
Financing — other-$2.0M-$27.0M-$92.0M——-$104.0M
Repayments of Long-Term Debt$0.0$2.5B$1.0B$1.5B$0.0$833.0M
Research and development expense$1.7B$1.5B$1.7B$1.9B$2.1B$1.7B
Revenue From Contract With Customer Excluding Assessed Tax$9.1B$8.1B$9.2B$9.6B$9.9B$8.6B
Stock-based compensation$134.0M$85.0M$157.0M$127.0M$125.0M$75.0M
Cash Dividends, Common Stock$1.2B$1.3B$1.3B$1.3B$1.3B$1.4B

Net Income

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Common Stock Dividends$1.2B$1.3B$1.3B$1.3B$1.3B$1.4B
Net income$627.0M$1.7B$1.4B$3.2B$1.3B$1.8B
Common Stock Dividends$1.2B$1.3B$1.3B$1.3B$1.3B$1.4B

Earnings Per Share

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Basic earnings per share$1.17$3.22$2.66$5.98$2.47$3.37
Diluted earnings per share$1.16$3.20$2.65$5.93$2.46$3.34
Weighted-average shares, basic—538M538M538M—540M
Weighted-average shares, diluted—541M541M542M—544M

Operating Income

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Gross profit$6.0B$5.2B$6.2B$6.5B$6.9B$5.9B
Operating income$2.3B$1.2B$2.7B$2.5B$2.7B$2.7B

Income Before Tax

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income before income taxes$782.0M$2.0B$1.6B$3.9B$1.5B$2.1B

Tax

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income tax expense$155.0M$243.0M$136.0M$705.0M$181.0M$265.0M
Deferred Income Tax Expense-$334.0M-$250.0M-$422.0M-$30.0M-$19.0M-$176.0M
Deferred and Other Income Taxes-$334.0M-$250.0M-$422.0M-$30.0M-$19.0M-$176.0M

Cost of Revenue

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Total cost of revenue$3.1B$3.0B$3.0B$3.1B$3.0B$2.7B

Revenue

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Total revenue$9.1B$8.1B$9.2B$9.6B$9.9B$8.6B